Novo Nordisk CEO: Aim is to expand weight-loss market in U.S. (2026-05-06)
Charlotte Reed speaks with Mike Doustdar, CEO of Novo Nordisk, after the Danish comapny hiked its 2026 full-year guidance on the back of increased expectations for GLP-1 product sales.